4//SEC Filing
Deutsch Barry M. 4
Accession 0000899243-18-018505
CIK 0001346302other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 8:38 PM ET
Size
7.1 KB
Accession
0000899243-18-018505
Insider Transaction Report
Form 4
Deutsch Barry M.
Chief Financial Officer
Transactions
- Conversion
Common Stock
2018-06-25+2,238→ 23,292 total - Conversion
Series C Preferred Stock
2018-06-25−3,987→ 0 total→ Common Stock (2,238 underlying)
Footnotes (1)
- [F1]Each share of Preferred Stock automatically converted into Common Stock, for no additional payment or consideration, on a 1.78112-for-1 basis at the closing of the Issuer's initial public offering on June 25, 2018 and had no expiration date.
Documents
Issuer
XERIS PHARMACEUTICALS INC
CIK 0001346302
Entity typeother
Related Parties
1- filerCIK 0001289407
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 8:38 PM ET
- Size
- 7.1 KB